Directors' dealings:BB Biotech AG:Director's Dealings announcement according to §15a WpHG (the German Securities Trading Act)
(Thomson Reuters ONE) -
BB Biotech AG / / Director's Dealings announcement according to §15a WpHG (the German Securities Trading Act) processed and transmitted by Hugin AS. The issuer is solely responsible for the content of this announcement.
--------------------------------------------------------------------------------
Details of the person subject to the disclosure requirement
--------------------------------------------------------------------------------
Name: Koller, Daniel
Professional role: Person with executive functions: Member of a managing
body
--------------------------------------------------------------------------------
Designation of the financial instrument
--------------------------------------------------------------------------------
ISIN: CH0038389992
Designation: Registered share BB BIOTECH
--------------------------------------------------------------------------------
Details of the transaction
--------------------------------------------------------------------------------
Type of transaction: Buy
Date: 21.05.2010
Place (stock exchange): SIX Swiss Exchange, Zürich
Price: 60.9968
Currency: CHF
Quantity: 1000
Business volume: 60996.80
--------------------------------------------------------------------------------
Details of the company with the publishing obligation:
--------------------------------------------------------------------------------
Issuer:
BB Biotech AG
Vordergasse 3
CH-8200 Schaffhausen
Switzerland
ISIN: CH0038389992
WKN: 888509
[HUG#1418653]
--- End of Message ---
BB Biotech AG
Vordergasse 3 Schaffhausen Switzerland
WKN: 888509;ISIN: CH0038389992;Index:TecDAX,Prime All Share,TECH All Share,HDAX,MIDCAP;
Listed: Regulierter Markt in Frankfurter Wertpapierbörse;
Unternehmensinformation / Kurzprofil:
Datum: 25.05.2010 - 18:50 Uhr
Sprache: Deutsch
News-ID 21436
Anzahl Zeichen: 0
contact information:
Town:
Schaffhausen
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 199 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Directors' dealings:BB Biotech AG:Director's Dealings announcement according to §15a WpHG (the German Securities Trading Act)"
steht unter der journalistisch-redaktionellen Verantwortung von
BB Biotech AG (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
